Inventor · disambiguated record
Karl-Heinz Thierauch
Also filed as: THIERAUCH KARL · THIERAUCH KARL H · THIERAUCH KARL-HEINZ
36 granted patents·31 pending applications·537 citations·filing 1987–2016
97Inventor score
Top patents by PatentIndex Score
67 records- 0195US6448277B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 10, 2002·64 cites·19 claims
- 0294US6878720B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2002·Granted Apr 12, 2005·50 cites·16 claims
- 0394US6225347B19-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agentsSCHERING AG·Filed 1994·Granted May 1, 2001·57 cites·20 claims
- 0492US8992932B2Binder-drug conjugates (ADCs) and use thereofSEATTLE GENETICS INC·Filed 2012·Granted Mar 31, 2015·26 cites·12 claims
- 0589US7002022B2N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGFSCHERING AG·Filed 2004·Granted Feb 21, 2006·24 cites·8 claims
- 0689US6818661B2Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitorsNOVARTIS AG·Filed 2001·Granted Nov 16, 2004·21 cites·5 claims
- 0786US7122547B1Anthranilic acid amides and the use thereof as medicamentsNOVARTIS AG·Filed 1999·Granted Oct 17, 2006·79 cites·14 claims
- 0886US5376683AΔ8- and Δ9-prostaglandin derivatives, process for their production and their pharmaceutical useSCHERING AG·Filed 1992·Granted Dec 27, 1994·27 cites·5 claims
- 0985US4886788ACyclodextrin clathrates of carbacyclin derivatives and their use as medicinal agentsSCHERING AG·Filed 1987·Granted Dec 12, 1989·40 cites·22 claims
- 1084US7148357B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesSCHERING AG·Filed 2003·Granted Dec 12, 2006·15 cites·3 claims
- 1183US7202260B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridonesSCHERING AG·Filed 2004·Granted Apr 10, 2007·11 cites·14 claims
- 1281US7615565B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 10, 2009·3 cites·9 claims
- 1381US7012081B2Anthranyl amides and their use as medicamentsSCHERING AG·Filed 2001·Granted Mar 14, 2006·14 cites·12 claims
- 1478US7846928B2Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Dec 7, 2010·4 cites·39 claims
- 1578US7429592B2Cyanoanthranilamide derivatives and the use thereof as medicamentsSCHERING AG·Filed 2002·Granted Sep 30, 2008·12 cites·10 claims
- 1676US7081468B2Ortho-substituted anthranilic acid amides and their use as medicamentsSCHERING AG·Filed 2001·Granted Jul 25, 2006·8 cites·4 claims
- 1773US7906533B2Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 15, 2011·1 cites·22 claims
- 1871US8642611B2Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2008·Granted Feb 4, 2014·2 cites·15 claims
- 1970US7795264B2Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Sep 14, 2010·1 cites·23 claims
- 2069US5405988A9-substituted bicyclo[3.3.0]octane derivatives, process for their production and their pharmaceutical useSCHERING AG·Filed 1992·Granted Apr 11, 1995·26 cites·22 claims
- 2165US8796253B2Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBOYER STEPHEN·Filed 2008·Granted Aug 5, 2014·1 cites·20 claims
- 2264US6344339B1Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR)SCHERING AG·Filed 1997·Granted Feb 5, 2002·23 cites·18 claims
- 2362US5891910A9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agentsSCHERING AG·Filed 1995·Granted Apr 6, 1999·8 cites·18 claims
- 2461US2015030618A1Novel binder-drug conjugates (adcs) and use thereofSEATTLE GENETICS INC·Filed 2014·Application pending·0 cites
- 2557US2014127240A1Novel Binder-Drug Conjugates (ADCs) and Use of SameLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 2657US2006074112A1N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitorsALTMANN KARL-HEINZ·Filed 2005·Application pending·0 cites
- 2757US2006287339A1Aza- and polyazanthranyl amides and their use as medicamentsSEIDELMANN DIETER·Filed 2006·Application pending·0 cites
- 2857US2013122024A1New binder-drug conjugates (adcs) and use thereofLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 2956US2007135489A1Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridonesHUTH ANDREAS·Filed 2007·Application pending·0 cites
- 3056US2013066055A1New binder-drug conjugates (adcs) and use thereofLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 3156US2016193359A1New binder-drug conjugates (adcs) and use thereofSEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 3255US7902229B2Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 8, 2011·0 cites·17 claims
- 3354US2015246136A1NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAMESEATTLE GENETICS INC·Filed 2015·Application pending·0 cites
- 3453US7479491B2Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitorsNOVARTIS AG·Filed 2004·Granted Jan 20, 2009·0 cites·3 claims
- 3552US2004039019A1Selected anthranilaminde pyridinamides and their use as pharmaceutical agentsSCHERING AG·Filed 2003·Application pending·0 cites
- 3652US2004147449A1Combinations and compositions which interfere with VEGF/ VEGF and angiopoietin/ Tie receptor function and their use (II)Filed 2004·Application pending·0 cites
- 3750US5010065ACyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use as pharmaceutical agentsSCHERING AG·Filed 1988·Granted Apr 23, 1991·14 cites·10 claims
- 3850US2011071165A1Aza- and polyazanthranyl amides and their use as medicamentsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 3949US2004224968A1Aza-and polyazanthranyl amides and their use as medicamentsFiled 2001·Application pending·0 cites
- 4048US8481539B2Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2008·Granted Jul 9, 2013·0 cites·9 claims
- 4148US2009005373A1Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2007·Application pending·0 cites
- 4247US2008039482A1Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2007·Application pending·0 cites
- 4347US2011312930A1Aryl compounds with aminoalkyl substituents and their useHAERTER MICHAEL·Filed 2009·Application pending·0 cites
- 4447US2013196964A1Heterocyclically substituted aryl compounds as hif inhibitorsHAERTER MICHAEL·Filed 2009·Application pending·0 cites
- 4547US2011301122A1Heteroaromatic compounds for use as hif inhibitorsHAERTER MICHAEL·Filed 2009·Application pending·0 cites
- 4646US8003655B2Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Aug 23, 2011·0 cites·23 claims
- 4746US2003055006A1Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their useSCHERING AG·Filed 2001·Application pending·0 cites
- 4845US7842809B2Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of sameBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 30, 2010·0 cites·25 claims
- 4945US7517894B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesBAYER SCHERING PHARMA AG·Filed 2004·Granted Apr 14, 2009·0 cites·11 claims
- 5044US7825114B2Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 2, 2010·0 cites·35 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Karl-Heinz Thierauch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →